Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Idea lost 25 lakh subscribers in May, most in nine months

15h moneycontrol
Idea Cellular lost around 25 lakh subscribers in May, the most among all wireless telecom operators in the country, according to data released by the Telecom Regulatory Authority of India (TRAI). This was the company’s biggest drop in subscriber numbers in nine months.
532454 IDEA ICLQY 532822 BHRQY BHARTIARTL

0
Idea, Vodafone may pay DoT ‘under protest’

2018-07-19 freepressjournal.in
Mumbai : Idea Cellular and Vodafone India are likely to clear dues worth Rs 7,268 crore in the next few weeks under protest to get the final nod from the DoT to go ahead, according to sources.
IDEA ICLQY 532822

0
Idea, Vodafone may pay DoT ‘under protest’

2018-07-19 freepressjournal.in
Mumbai : Idea Cellular and Vodafone India are likely to clear dues worth Rs 7,268 crore in the next few weeks under protest to get the final nod from the DoT to go ahead, according to sources.
IDEA ICLQY 532822

0
DoT looking into Vodafone-Idea plea on recalculating dues

2018-07-18 livemint
New Delhi: Vodafone and Idea Cellular have cited “some difference of opinion” on the way dues have been computed by the government, which is “looking into” the issue, telecom secretary Aruna Sundararajan said on Wednesday.
532454 IDEA ICLQY 532822 BHRQY BHARTIARTL

1
Podcast | Sensex ends almost 150 pts lower, Nifty below 11K; midcaps take a hit

2018-07-18 moneycontrol
Intensified selling in the last hour ensured that the market ended the day on a lower note, with the Nifty giving up 11,000-mark. The Sensex managed to close almost 150 points lower, a huge drop from the record high it achieved on Wednesday morning.
500820 JIPKY HTMEDIA JPASSOCIAT ICLQY 532822 ASIANPAINT 532532 532662 500470 TTST TATASTEEL TATLY HDB 500180 IDEA HDFCBANK

0
Idea falls 8% on report that co, Voda may pay Rs 7,200-cr spectrum dues to DoT to avoid merger delay

2018-07-18 moneycontrol
Shares of Idea Cellular fell almost 8 percent on Wednesday afternoon as investors turned wary of the Idea and Vodafone’s decision to pay spectrum dues in a few weeks.
IDEA ICLQY 532822

1
An evening walk down Dalal Street | Sensex ends almost 150 pts lower, Nifty below 11K

2018-07-18 moneycontrol
Intensified selling in the last hour ensured that the market ended the day on a lower note, with the Nifty giving up 11,000-mark. The Sensex managed to close almost 150 points lower, a huge drop from the record high it achieved on Wednesday morning.
NIITTECH 500820 JIPKY HTMEDIA JPASSOCIAT ICLQY 532822 532712 ASIANPAINT 532532 532662 532541 500470 TTST RCOM TATASTEEL TATLY HDB 500180 IDEA HDFCBANK

0
DoT rejects Vodafone-Idea request to recalculate dues

2018-07-18 moneycontrol
The Department of Telecommunications (DoT) has rejected a request by Vodafone India and Idea seeking to recalculate their dues, according to a report by The Economic Times.
IDEA ICLQY 532822

0
Jio tops 4G download speed; Idea in upload rate for May 2018

2018-07-17 moneycontrol
Reliance Jio has topped the chart of fastest 4G telecom operators with an average peak download speed of 22.3 mbps on its network while Idea Cellular registered highest upload speed in May, according to a Trai report.
532454 IDEA ICLQY 532822 BHRQY BHARTIARTL

0
#39;India Inc raised $3.8 bn through 19 IPOs in Jan-Jun this year#39;

2018-07-17 moneycontrol
Corporate India raised $3.8 billion through 19 IPOs in the first half of this year, largely driven by stable equity markets, says a report. According to Grant Thornton, increased activity in the IPO space is expected as the IPO ecosystem is evolving at a rapid pace and several companies are looking to list this year.
IDEA ICLQY 532822

22
Podcast | Deep dive: 5G technology in India

2018-07-16 moneycontrol
5G, the next big milestone in telecom technology, is just around the corner. Yep, even in India. 5G has been in trials for a while now and has been covered pretty widely. I recall a tiff between two companies that showed off a 5G-enabled bus and a 5G-enabled self-driven car, respectively, at the South Korea winter Olympics in February of this year.
RSYS RCOM IDEA ICLQY 532712 532822

1
An evening walk down Dalal Street | Nifty ends flat but holds 11K, Sensex gives up all of its gains

2018-07-13 moneycontrol
The market took a breather on last day of the week as benchmark indices closed in the red on Friday after rallying sharply in the previous session.
500325 500116 AXB IBN 532706 RELIANCE IDBI INOXLEISUR ICLQY 532822 532215 AXBKY AXBA ICICIBANK AXISBANK HDB 532174 500180 RIGD IDEA HDFCBANK RLNIY

0
Idea Cellular to bear Vodafone India liabilities worth Rs 13,600cr before final DoT merger approval

2018-07-13 moneycontrol
The Department of Telecommunications (DoT) requires Idea Cellular to provide bank guarantees and payments for the spectrum bought by Vodafone India before final approval for their merger is granted.
IDEA ICLQY 532822

0
Idea Cellular slips nearly 3% after Credit Suisse maintains Underperform, sees 17% downside

2018-07-13 moneycontrol
Idea Cellular share price fell 2.7 percent intraday on Friday after global research firm Credit Suisse maintained its Underperform rating on the stock with a target price at Rs 45, implying a 17 percent downside.
532454 IDEA ICLQY 532822 BHRQY BHARTIARTL

0
RCom sees bias in DoT not seeking bank guarantees from Vodafone

2018-07-12 livemint
New Delhi: Reliance Communications has alleged DoT of adopting a discriminatory approach by demanding bank guarantee from the company for one-time spectrum charges, while approving the Vodafone-Idea Cellular merger without making a similar demand, sources said today.
532662 RCOM IDEA HTMEDIA ICLQY 532712 532822

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...